The Annals of thoracic surgery · 2012
Plastic bronchitis after extracardiac Fontan operation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Grutter Giorgia, Di Carlo Duccio, Gandolfo Fabrizio, Adorisio Rachele, Alfieri Sara, Michielon Guido, Carotti Adriano, Pongiglione Giacomo
Аннотация
BACKGROUND: We discuss 4 cases of plastic bronchitis (PB) after Fontan procedure observed at our Institution, with the aim to identify an effective treatment and possible factors favoring the onset of PB. Plastic bronchitis is an uncommon disease characterized by recurrent formation of large pale bronchial casts obstructing the tracheobronchial tree. The treatment includes inhaled or systemic steroids, aerosolized mucolytics, bronchoscopic lavage, direct bronchoscopic extraction and, in few reports, aerosolized fibrinolytic and pulmonary vasodilators.
METHODS: Four cases of PB after Fontan procedure occurred in our center from January 2008 to January 2012.
RESULTS: All patients showed preserved ventricle function and underwent embolization of systemic-pulmonary collaterals prior to a Fontan procedure and all had chylothorax in the perioperative period. Two patients died; 1 of massive thrombosis of the superior vena cava and right pulmonary artery and the other of acute asphyxiation and refractory cardiac failure.
CONCLUSIONS: The exact causes of PB in Fontan patients remain unknown. An early diagnosis and a multiple therapy with steroids, mucolytics, pulmonary vasodilators, and aerosolized tissue plasminogen activator may be effective.
METHODS: Four cases of PB after Fontan procedure occurred in our center from January 2008 to January 2012.
RESULTS: All patients showed preserved ventricle function and underwent embolization of systemic-pulmonary collaterals prior to a Fontan procedure and all had chylothorax in the perioperative period. Two patients died; 1 of massive thrombosis of the superior vena cava and right pulmonary artery and the other of acute asphyxiation and refractory cardiac failure.
CONCLUSIONS: The exact causes of PB in Fontan patients remain unknown. An early diagnosis and a multiple therapy with steroids, mucolytics, pulmonary vasodilators, and aerosolized tissue plasminogen activator may be effective.
Предметные рубрики MeSH
Administration, InhalationAdrenal Cortex HormonesAirway ObstructionBronchitisBronchoalveolar Lavage FluidBronchoscopyCardiac CatheterizationChild, PreschoolDrug Therapy, CombinationFemaleFibrinolytic AgentsFollow-Up StudiesFontan ProcedureHeart Defects, CongenitalHumansMalePostoperative ComplicationsRare DiseasesRetrospective StudiesRisk AssessmentSampling StudiesTreatment OutcomeVasodilator Agents